Team Portfolio Raise Read Contact

F4/MBX Capital/Activity

MBX Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in Think Bioscience's $55M oversubscribed Series A for synthetic biology drug discovery.

Think Bioscience

Think Bioscience MBX Capital

prnewswire.comJAN 2026

JAN 2026

MBX Capital — Activity | F4

News

Crossed $100M+ in cumulative capital commitments with sharpened thesis focused on environmental toxins and chronic disease prevention.

$100M+ cumulative commitments and environmental toxins thesis focus

hitconsultant.netDEC 2025

DEC 2025

Investment

Participated as existing investor in Vivodyne's $40M Series A for AI-powered human tissue testing replacing animal models.

Vivodyne

Vivodyne MBX Capital

finsmes.comMAY 2025

MAY 2025

Investment

Participated in Persist AI's Series A for cloud-based pharmaceutical formulation screening using AI and robotics.

Persist AI

Persist AI MBX Capital

builtincolorado.comMAY 2025

MAY 2025